HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization

11/08/2021
by   Eduardo Conde-Sousa, et al.
10

Breast cancer is the most common malignancy in women, being responsible for more than half a million deaths every year. As such, early and accurate diagnosis is of paramount importance. Human expertise is required to diagnose and correctly classify breast cancer and define appropriate therapy, which depends on the evaluation of the expression of different biomarkers such as the transmembrane protein receptor HER2. This evaluation requires several steps, including special techniques such as immunohistochemistry or in situ hybridization to assess HER2 status. With the goal of reducing the number of steps and human bias in diagnosis, the HEROHE Challenge was organized, as a parallel event of the 16th European Congress on Digital Pathology, aiming to automate the assessment of the HER2 status based only on hematoxylin and eosin stained tissue sample of invasive breast cancer. Methods to assess HER2 status were presented by 21 teams worldwide and the results achieved by some of the proposed methods open potential perspectives to advance the state-of-the-art.

READ FULL TEXT

Authors

page 8

page 9

page 10

page 11

06/17/2012

An Analysis of the Methods Employed for Breast Cancer Diagnosis

Breast cancer research over the last decade has been tremendous. The gro...
03/15/2021

Exploring Genetic-histologic Relationships in Breast Cancer

The advent of digital pathology presents opportunities for computer visi...
08/13/2018

BACH: Grand Challenge on Breast Cancer Histology Images

Breast cancer is the most common invasive cancer in women, affecting mor...
06/21/2016

Crowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational Method

The assessment of protein expression in immunohistochemistry (IHC) image...
01/14/2021

O^2PF: Oversampling via Optimum-Path Forest for Breast Cancer Detection

Breast cancer is among the most deadly diseases, distressing mostly wome...
04/25/2022

BCI: Breast Cancer Immunohistochemical Image Generation through Pyramid Pix2pix

The evaluation of human epidermal growth factor receptor 2 (HER2) expres...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.